Concepts (149)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Germ-Line Mutation | 20 | 2024 | 1858 | 3.090 |
Why?
|
Genetic Counseling | 10 | 2024 | 627 | 2.370 |
Why?
|
Genetic Testing | 18 | 2024 | 3537 | 1.810 |
Why?
|
Fumarate Hydratase | 2 | 2024 | 52 | 1.680 |
Why?
|
Genetic Predisposition to Disease | 29 | 2024 | 17904 | 1.510 |
Why?
|
Li-Fraumeni Syndrome | 4 | 2021 | 117 | 1.470 |
Why?
|
Tumor Suppressor Protein p53 | 5 | 2023 | 2917 | 0.860 |
Why?
|
von Hippel-Lindau Disease | 1 | 2021 | 151 | 0.710 |
Why?
|
Leiomyoma | 1 | 2024 | 636 | 0.650 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2021 | 592 | 0.590 |
Why?
|
Inflammatory Breast Neoplasms | 1 | 2019 | 147 | 0.560 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2020 | 339 | 0.550 |
Why?
|
Breast Neoplasms | 9 | 2024 | 21012 | 0.550 |
Why?
|
Paraganglioma | 2 | 2018 | 142 | 0.550 |
Why?
|
Neoplasms | 12 | 2024 | 22170 | 0.530 |
Why?
|
Ovarian Neoplasms | 3 | 2023 | 4876 | 0.520 |
Why?
|
Heterozygote | 4 | 2019 | 2787 | 0.520 |
Why?
|
Gaucher Disease | 2 | 2014 | 110 | 0.500 |
Why?
|
Glucosylceramidase | 2 | 2014 | 127 | 0.500 |
Why?
|
Uterine Neoplasms | 1 | 2024 | 1420 | 0.490 |
Why?
|
Neoplastic Syndromes, Hereditary | 3 | 2022 | 245 | 0.430 |
Why?
|
High-Throughput Screening Assays | 1 | 2018 | 934 | 0.410 |
Why?
|
Pheochromocytoma | 1 | 2014 | 328 | 0.390 |
Why?
|
BRCA1 Protein | 3 | 2023 | 1155 | 0.370 |
Why?
|
Genes, BRCA2 | 3 | 2023 | 601 | 0.360 |
Why?
|
Patient Compliance | 1 | 2020 | 2690 | 0.350 |
Why?
|
Germ Cells | 6 | 2023 | 634 | 0.340 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2022 | 2223 | 0.340 |
Why?
|
Pedigree | 5 | 2021 | 4542 | 0.320 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2014 | 732 | 0.310 |
Why?
|
Carcinoma, Lobular | 2 | 2024 | 481 | 0.310 |
Why?
|
Prostatic Neoplasms | 4 | 2023 | 11118 | 0.300 |
Why?
|
Thyroid Neoplasms | 1 | 2020 | 2332 | 0.290 |
Why?
|
Colorectal Neoplasms | 4 | 2022 | 6935 | 0.280 |
Why?
|
Counseling | 1 | 2014 | 1547 | 0.260 |
Why?
|
Succinate Dehydrogenase | 2 | 2017 | 145 | 0.250 |
Why?
|
Middle Aged | 22 | 2024 | 220895 | 0.230 |
Why?
|
Female | 33 | 2024 | 392644 | 0.230 |
Why?
|
Leiomyomatosis | 1 | 2024 | 69 | 0.220 |
Why?
|
Phenotype | 5 | 2022 | 16591 | 0.220 |
Why?
|
Humans | 51 | 2024 | 761504 | 0.220 |
Why?
|
Puerperal Disorders | 1 | 2006 | 299 | 0.210 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2017 | 380 | 0.210 |
Why?
|
Genetic Association Studies | 3 | 2021 | 2735 | 0.200 |
Why?
|
Estrogens, Conjugated (USP) | 1 | 2023 | 276 | 0.200 |
Why?
|
Parkinson Disease | 2 | 2014 | 2877 | 0.200 |
Why?
|
Neoplasm Proteins | 1 | 2014 | 3617 | 0.190 |
Why?
|
Adult | 23 | 2024 | 221177 | 0.190 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2006 | 513 | 0.190 |
Why?
|
Genetic Variation | 4 | 2021 | 6567 | 0.190 |
Why?
|
Carcinoma, Signet Ring Cell | 1 | 2021 | 82 | 0.190 |
Why?
|
Electronics | 1 | 2022 | 318 | 0.180 |
Why?
|
Genotype | 4 | 2024 | 12990 | 0.180 |
Why?
|
Access to Information | 1 | 2023 | 316 | 0.180 |
Why?
|
Family | 3 | 2023 | 3194 | 0.180 |
Why?
|
Penetrance | 3 | 2022 | 383 | 0.180 |
Why?
|
Male | 25 | 2023 | 360804 | 0.170 |
Why?
|
Medical History Taking | 2 | 2020 | 774 | 0.170 |
Why?
|
Proto-Oncogene Proteins c-ret | 1 | 2020 | 225 | 0.160 |
Why?
|
BRCA2 Protein | 1 | 2023 | 805 | 0.160 |
Why?
|
Saliva | 1 | 2021 | 828 | 0.140 |
Why?
|
Retrospective Studies | 6 | 2024 | 80636 | 0.140 |
Why?
|
Cadherins | 1 | 2021 | 903 | 0.140 |
Why?
|
Extracellular Matrix Proteins | 1 | 2021 | 829 | 0.140 |
Why?
|
Adrenocortical Carcinoma | 1 | 2017 | 88 | 0.140 |
Why?
|
Prevalence | 4 | 2021 | 15732 | 0.140 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2024 | 1085 | 0.130 |
Why?
|
Venous Thrombosis | 1 | 2006 | 1303 | 0.130 |
Why?
|
Telomerase | 1 | 2021 | 745 | 0.130 |
Why?
|
Adrenal Cortex Neoplasms | 1 | 2017 | 161 | 0.130 |
Why?
|
Young Adult | 12 | 2021 | 59243 | 0.120 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2022 | 3639 | 0.120 |
Why?
|
Thyroidectomy | 1 | 2020 | 907 | 0.120 |
Why?
|
Genes, BRCA1 | 1 | 2019 | 764 | 0.120 |
Why?
|
Aged, 80 and over | 8 | 2021 | 58976 | 0.120 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2017 | 455 | 0.120 |
Why?
|
Jews | 1 | 2014 | 356 | 0.100 |
Why?
|
Pulmonary Embolism | 1 | 2006 | 2567 | 0.100 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2018 | 1136 | 0.100 |
Why?
|
Tumor Suppressor Proteins | 2 | 2022 | 2803 | 0.100 |
Why?
|
Stomach Neoplasms | 1 | 2021 | 1459 | 0.090 |
Why?
|
Alleles | 1 | 2022 | 6863 | 0.090 |
Why?
|
Myelodysplastic Syndromes | 1 | 2021 | 1394 | 0.090 |
Why?
|
Gene Frequency | 1 | 2018 | 3606 | 0.090 |
Why?
|
Melanoma | 2 | 2022 | 5709 | 0.090 |
Why?
|
Antigens, CD | 1 | 2021 | 4003 | 0.090 |
Why?
|
Neoplasms, Second Primary | 1 | 2019 | 1052 | 0.090 |
Why?
|
Sequence Analysis, DNA | 3 | 2021 | 4740 | 0.090 |
Why?
|
Skin Neoplasms | 2 | 2022 | 5821 | 0.090 |
Why?
|
Kidney Neoplasms | 3 | 2021 | 4249 | 0.090 |
Why?
|
Incidence | 3 | 2022 | 21353 | 0.090 |
Why?
|
Promoter Regions, Genetic | 1 | 2021 | 5789 | 0.080 |
Why?
|
RNA | 1 | 2019 | 2726 | 0.080 |
Why?
|
Mutation | 6 | 2017 | 30052 | 0.080 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2023 | 4016 | 0.080 |
Why?
|
Medical Oncology | 1 | 2020 | 2321 | 0.080 |
Why?
|
Aged | 10 | 2021 | 169289 | 0.080 |
Why?
|
Survival Rate | 2 | 2021 | 12725 | 0.080 |
Why?
|
Carcinoma, Renal Cell | 2 | 2021 | 3164 | 0.080 |
Why?
|
Carcinoma | 1 | 2019 | 2330 | 0.080 |
Why?
|
Healthcare Disparities | 1 | 2023 | 3358 | 0.070 |
Why?
|
Referral and Consultation | 1 | 2020 | 3600 | 0.070 |
Why?
|
Family Health | 1 | 2012 | 1257 | 0.070 |
Why?
|
Massachusetts | 1 | 2019 | 8830 | 0.070 |
Why?
|
DNA Mutational Analysis | 1 | 2014 | 4111 | 0.060 |
Why?
|
Adolescent | 7 | 2021 | 88319 | 0.060 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2021 | 15936 | 0.060 |
Why?
|
DNA Mismatch Repair | 1 | 2017 | 428 | 0.060 |
Why?
|
Prospective Studies | 4 | 2022 | 54425 | 0.060 |
Why?
|
Follow-Up Studies | 3 | 2021 | 39106 | 0.060 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7390 | 0.050 |
Why?
|
Hematologic Neoplasms | 1 | 2014 | 1896 | 0.050 |
Why?
|
Cohort Studies | 3 | 2021 | 41487 | 0.050 |
Why?
|
Sequence Analysis | 1 | 2022 | 240 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 1 | 2012 | 6484 | 0.050 |
Why?
|
Genome-Wide Association Study | 1 | 2021 | 12690 | 0.050 |
Why?
|
Genealogy and Heraldry | 1 | 2021 | 29 | 0.050 |
Why?
|
Heart Defects, Congenital | 1 | 2018 | 4671 | 0.050 |
Why?
|
Child, Preschool | 2 | 2021 | 42230 | 0.050 |
Why?
|
Child | 5 | 2021 | 80153 | 0.050 |
Why?
|
Microphthalmia-Associated Transcription Factor | 1 | 2022 | 259 | 0.040 |
Why?
|
Genes, Neoplasm | 1 | 2021 | 370 | 0.040 |
Why?
|
Time Factors | 1 | 2020 | 39967 | 0.040 |
Why?
|
Prognosis | 1 | 2019 | 29625 | 0.040 |
Why?
|
Oncogenes | 1 | 2024 | 1222 | 0.040 |
Why?
|
Cyanosis | 1 | 2018 | 82 | 0.040 |
Why?
|
Haplotypes | 1 | 2023 | 2713 | 0.040 |
Why?
|
Risk Factors | 4 | 2016 | 74206 | 0.030 |
Why?
|
Age Factors | 1 | 2012 | 18395 | 0.030 |
Why?
|
United States | 4 | 2023 | 72334 | 0.030 |
Why?
|
Risk Assessment | 2 | 2016 | 23995 | 0.030 |
Why?
|
Genomics | 2 | 2024 | 5821 | 0.030 |
Why?
|
Risk | 2 | 2019 | 9610 | 0.030 |
Why?
|
Pregnancy | 2 | 2024 | 29874 | 0.030 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2022 | 1897 | 0.030 |
Why?
|
Mesothelioma | 1 | 2017 | 807 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2021 | 6814 | 0.020 |
Why?
|
Mastectomy | 1 | 2019 | 1822 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2017 | 1742 | 0.020 |
Why?
|
Age of Onset | 1 | 2014 | 3305 | 0.020 |
Why?
|
Decision Making | 1 | 2019 | 3929 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 2017 | 9031 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2022 | 9606 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2023 | 26125 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2016 | 14605 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 2017 | 6346 | 0.010 |
Why?
|
Pancreatic Neoplasms | 1 | 2016 | 5368 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2019 | 64680 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2017 | 13380 | 0.010 |
Why?
|
Concepts
(149)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(79)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_